MediFind found 5 doctor with experience in HER2 Negative Breast Cancer near Dover, DE. Of these, 4 are Experienced and 1 are Advanced.
Dedicated To Women Ob-Gyn, P.A.
Wendy Newell is a General Surgeon in Dover, Delaware. Dr. Newell is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Fibrocystic Breast Disease, Breast Infection, Breast Cancer, Gastrostomy, and Hernia Surgery. Dr. Newell is currently accepting new patients.
Bayhealth Medical Center, Inc
Rishi Sawhney is a Hematologist in Dover, Delaware. Dr. Sawhney is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Paget Disease of the Breast, Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Breast Cancer.
Dedicated To Women Ob-Gyn, P.A.
Robert Scacheri is an Obstetrics and Gynecologist in Dover, Delaware. Dr. Scacheri is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Menorrhagia, Pelvic Inflammatory Disease, Vulvovaginitis, Intrauterine Device Insertion, and Hormone Replacement Therapy (HRT). Dr. Scacheri is currently accepting new patients.
Dedicated To Women Ob-Gyn, P.A.
Robert Hartmann is an Obstetrics and Gynecologist in Dover, Delaware. Dr. Hartmann is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Uterine Fibroids, Angiomyoma, Pelvic Inflammatory Disease, Intrauterine Device Insertion, and Salpingo-Oophorectomy. Dr. Hartmann is currently accepting new patients.
Dedicated To Women Ob-Gyn, P.A.
Justine Kline is a Physician Assistant in Dover, Delaware. Ms. Kline is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Gallbladder Disease, HER2 Negative Breast Cancer, and BRCA Positive Breast Cancer. Ms. Kline is currently accepting new patients.
Last Updated: 10/30/2025